Viz.ai One
Viz.ai One is an AI-powered care-coordination platform for healthcare organizations. It analyzes medical data, including imaging, to flag suspected diseases and connect care teams through alerts and workflow tools.
Why Abandoned
Viz.ai continues to present Viz.ai One and related disease-specific modules on its official website, while recent company announcements describe ongoing platform expansion and regulatory clearances.
🩺 Health Signals
No checks have been run on this tool yet.
📅 Timeline
Viz.ai founded
Viz LVO receives FDA clearance
Viz.ai raises $100 million Series D
Viz.ai launches Viz HCM
🪦 Other dead Healthcare tools
Kheiron Mia
🟡Acquired / MergedMia is Kheiron Medical Technologies’ artificial intelligence platform for breast-screening mammography. It supports radiologists by analyzing mammograms and identifying cases that may warrant further review.
MaxQ AI ACCIPIO
🟠Possibly DeadACCIPIO was MaxQ AI's clinical AI platform for analyzing non-contrast head CT scans and prioritizing suspected intracranial hemorrhage cases for radiologist review. It was a triage aid, not a standalone diagnosis system.
Arterys Cardio AI
🟡Acquired / MergedCloud-based cardiac MRI analysis software that used machine learning to assist clinicians with image segmentation, ventricular measurements, and cardiac function assessment. Tempus acquired Arterys in 2022.
Zebra Medical Vision Imaging Analytics
🟡Acquired / MergedAI-based medical imaging analytics developed by Zebra Medical Vision to help identify findings in radiology scans. Nanox acquired Zebra in 2021 and incorporated its software into the Nanox.AI portfolio.
❓ Frequently Asked Questions
What is Viz.ai One?
Viz.ai One is a healthcare AI and care-coordination platform that brings disease-detection algorithms, patient information, team communication, and workflow tools into a shared clinical environment.
How does Viz.ai One work?
The platform connects with hospital systems, processes supported medical data such as imaging, and can alert appropriate clinicians when its software identifies a suspected condition. Available functions depend on the deployed module and local configuration.
What conditions does Viz.ai One support?
Viz.ai markets disease-specific solutions across areas including neurovascular, cardiovascular, and other acute or complex-care workflows. Specific availability and regulatory status vary by product, condition, and jurisdiction.
Is Viz.ai One FDA cleared?
The platform includes individual software modules with FDA clearances, including Viz LVO. A clearance applies to the named module and intended use, not automatically to every capability offered under the broader Viz.ai One platform.
Is Viz.ai One still active?
Yes. Viz.ai continues to market Viz.ai One and announce new integrations, clinical modules, and regulatory milestones. There is no verified announcement that the platform has been discontinued.